Juniper
1 known investors
Juniper Biosciences develops radiopharmaceuticals for oncology, using radioisotopes and high-specificity ligands for targeted diagnostics and therapeutic delivery. It is advancing a pipeline of theranostic agents across multiple disease states, including a candidate for HPV-positive head and neck cancer.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Juniper do?
- Juniper Biosciences develops radiopharmaceuticals for oncology, using radioisotopes and high-specificity ligands for targeted diagnostics and therapeutic delivery. It is advancing a pipeline of theranostic agents across multiple disease states, including a candidate for HPV-positive head and neck cancer.
- Who are Juniper's investors?
- Juniper's investors include NovaCapital.